Christine Choi
Partner @ M13
Christine Choi is a seed investor at M13 focused on Medical and Biopharma. Christine Choi is based out of New York, New York and is the Partner of M13. Christine previously worked at Virgin Galactic as a Head of Communications. Christine Choi attended Williams College.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Christine Choi invests in
Stages Christine Choi invests in
Countries Christine Choi invests in
Investment Focus
Industry
- Medical 1 (100%)
- Biopharma 1 (100%)
- Health Care 1 (100%)
- Biotechnology 1 (100%)
- Pharmaceutical 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
Adyn is a precision medicine company that develops personalized birth control methods.It provides medically actionable scientific insights and empowers individuals to proactively optimize their health—from birth control to fertility and beyond. The company's first product, the Birth Control Optimization Test, is an at-home kit enabling usersto collect both saliva and finger prick samples to measure hormone baseline levels and aims to assess genetic risk for blood clots and depression. Adyn's technology then synthesizes a medical biography with side effect profiles of estrogens and progestins used in hormonal contraception.Elizabeth Ruzzo headquartered the company in Seattle, Washington in 2019 and is backed by Lux Capital, M13, Civilization Ventures, Concrete Rose Capital, Y Combinator, Madrona Pioneer Fund, and Ascend VC. | $2.5M / Seed / Apr 19, 2021 |
Co-Investors
About M13
M13 provides strategic counsel and operational expertise to help founders grow their companies. Through Fund II, M13 will expand its focus to emerging technologies driving change in consumer behavior over the next decade. Founded in 2016 with offices in Los Angeles, New York, and San Francisco.
M13 Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Christine Choi
Partner
|
|||
|
Courtney Reum
Partner, Co-Founder
|
|||
|
Karl Alomar
Managing Partner
|
|||
|
Latif Peracha
General Partner
|
|||
|
Matt Hoffman
Partner, Head of Talent
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Christine Choi invest in?
Christine Choi invests primarily in Medical, Biopharma and Health Care startups, most often at Seed stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Christine Choi last invest?
The most recent investment recorded for Christine Choi closed in Apr 2021. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!